Literature DB >> 5048301

Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.

J D Maxwell, M Carrella, J D Parkes, R Williams, G P Mould, S H Curry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5048301     DOI: 10.1042/cs0430143

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  17 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

3.  Sedation in liver disease.

Authors: 
Journal:  Br Med J       Date:  1977-05-14

Review 4.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

5.  Effects of liver disease and of aging on the disposition and elimination of sedatives.

Authors:  S Schenker
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

Review 6.  Pharmacokinetic evaluation of hemodialysis in acute drug overdose.

Authors:  S Takki; J G Gambertoglio; D H Honda; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

Review 7.  Some clinical features of liver cell failure: an appraisal of their causes.

Authors:  A E Read
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

8.  Safe prescribing in liver disease.

Authors: 
Journal:  Br Med J       Date:  1973-04-28

Review 9.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 10.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.